Status: current, Defined. Date: 31-Jan 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3198381000168119 | Xadago (safinamide 50 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3198391000168116 | Xadago 50 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xadago 50 mg tablet | Is a | Xadago | true | Inferred relationship | Some | ||
| Xadago 50 mg tablet | Is a | safinamide 50 mg tablet | true | Inferred relationship | Some | ||
| Xadago 50 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xadago 50 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Xadago 50 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1192138333 | |
| Xadago 50 mg tablet | has Australian BoSS | safinamide | true | Inferred relationship | Some | 1192138332 | |
| Xadago 50 mg tablet | has intended active ingredient | safinamide | true | Inferred relationship | Some | 1192138332 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xadago 50 mg tablet, 30 | has TPUU | True | Xadago 50 mg tablet | Inferred relationship | Some | 1 |
| Xadago 50 mg tablet, 30, blister pack | has TPUU | True | Xadago 50 mg tablet | Inferred relationship | Some | 1 |
| Xadago 50 mg tablet, 10 | has TPUU | True | Xadago 50 mg tablet | Inferred relationship | Some | 1 |
| Xadago 50 mg tablet, 10, blister pack | has TPUU | True | Xadago 50 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR